Interferon therapy for multiple sclerosis.
Laboratory findings that suppressor cell function is improved with beta interferon therapy and that gamma interferon activity is inhibited by beta interferon provide support for the hypothesis that beta interferon will have a significant therapeutic effect on relapse rates in multiple sclerosis.